Global CRISPR & Cas Genes Market Growth (Status and Outlook) 2025-2031
According to this study, the global CRISPR & Cas Genes market size will reach US$ million by 2031.
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral (i.e. anti-phage) defense system of prokaryotes.
Cas9 (or 'CRISPR-associated protein 9') is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.
Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
United States market for CRISPR & Cas Genes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for CRISPR & Cas Genes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for CRISPR & Cas Genes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key CRISPR & Cas Genes players cover CRISPR Therapeutics, AstraZeneca, Addgene, Caribou Biosciences, Inc., Cellectis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “CRISPR & Cas Genes Industry Forecast” looks at past sales and reviews total world CRISPR & Cas Genes sales in 2024, providing a comprehensive analysis by region and market sector of projected CRISPR & Cas Genes sales for 2025 through 2031. With CRISPR & Cas Genes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR & Cas Genes industry.
This Insight Report provides a comprehensive analysis of the global CRISPR & Cas Genes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR & Cas Genes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRISPR & Cas Genes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR & Cas Genes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR & Cas Genes.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR & Cas Genes market by product type, application, key players and key regions and countries.
Segmentation by Type:
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral (i.e. anti-phage) defense system of prokaryotes.
Cas9 (or 'CRISPR-associated protein 9') is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.
Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
United States market for CRISPR & Cas Genes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for CRISPR & Cas Genes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for CRISPR & Cas Genes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key CRISPR & Cas Genes players cover CRISPR Therapeutics, AstraZeneca, Addgene, Caribou Biosciences, Inc., Cellectis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “CRISPR & Cas Genes Industry Forecast” looks at past sales and reviews total world CRISPR & Cas Genes sales in 2024, providing a comprehensive analysis by region and market sector of projected CRISPR & Cas Genes sales for 2025 through 2031. With CRISPR & Cas Genes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR & Cas Genes industry.
This Insight Report provides a comprehensive analysis of the global CRISPR & Cas Genes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR & Cas Genes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRISPR & Cas Genes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR & Cas Genes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR & Cas Genes.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR & Cas Genes market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Vector-based Cas
- DNA-free Cas
- Cell Line Engineering
- Biotechnology and Pharmaceutical Companies
- Academics and Government Research Institutes
- Contract Research Organizations (CROs)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CRISPR Therapeutics
- AstraZeneca
- Addgene
- Caribou Biosciences, Inc.
- Cellectis
- Editas Medicine, Inc.
- Egenesis
- F. Hoffmann-La Roche Ltd.
- Horizon Discovery Group Plc
- Genscrip
- Danaher Corporation
- Intellia Therapeutics, Inc.
- Lonza
- Merck KGaA
- New England BioLabs
- Takara Bio, Inc.
- Synthego
- Mammoth Biosciences
- Inscripta, Inc.
- Cibus
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CRISPR & Cas Genes Market Size (2020-2031)
2.1.2 CRISPR & Cas Genes Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CRISPR & Cas Genes by Country/Region (2020, 2024 & 2031)
2.2 CRISPR & Cas Genes Segment by Type
2.2.1 Vector-based Cas
2.2.2 DNA-free Cas
2.2.3 Cell Line Engineering
2.3 CRISPR & Cas Genes Market Size by Type
2.3.1 CRISPR & Cas Genes Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
2.4 CRISPR & Cas Genes Segment by Application
2.4.1 Biotechnology and Pharmaceutical Companies
2.4.2 Academics and Government Research Institutes
2.4.3 Contract Research Organizations (CROs)
2.5 CRISPR & Cas Genes Market Size by Application
2.5.1 CRISPR & Cas Genes Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
3 CRISPR & CAS GENES MARKET SIZE BY PLAYER
3.1 CRISPR & Cas Genes Market Size Market Share by Player
3.1.1 Global CRISPR & Cas Genes Revenue by Player (2020-2025)
3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Player (2020-2025)
3.2 Global CRISPR & Cas Genes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR & CAS GENES BY REGION
4.1 CRISPR & Cas Genes Market Size by Region (2020-2025)
4.2 Global CRISPR & Cas Genes Annual Revenue by Country/Region (2020-2025)
4.3 Americas CRISPR & Cas Genes Market Size Growth (2020-2025)
4.4 APAC CRISPR & Cas Genes Market Size Growth (2020-2025)
4.5 Europe CRISPR & Cas Genes Market Size Growth (2020-2025)
4.6 Middle East & Africa CRISPR & Cas Genes Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CRISPR & Cas Genes Market Size by Country (2020-2025)
5.2 Americas CRISPR & Cas Genes Market Size by Type (2020-2025)
5.3 Americas CRISPR & Cas Genes Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR & Cas Genes Market Size by Region (2020-2025)
6.2 APAC CRISPR & Cas Genes Market Size by Type (2020-2025)
6.3 APAC CRISPR & Cas Genes Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CRISPR & Cas Genes Market Size by Country (2020-2025)
7.2 Europe CRISPR & Cas Genes Market Size by Type (2020-2025)
7.3 Europe CRISPR & Cas Genes Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CRISPR & Cas Genes by Region (2020-2025)
8.2 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2020-2025)
8.3 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CRISPR & CAS GENES MARKET FORECAST
10.1 Global CRISPR & Cas Genes Forecast by Region (2026-2031)
10.1.1 Global CRISPR & Cas Genes Forecast by Region (2026-2031)
10.1.2 Americas CRISPR & Cas Genes Forecast
10.1.3 APAC CRISPR & Cas Genes Forecast
10.1.4 Europe CRISPR & Cas Genes Forecast
10.1.5 Middle East & Africa CRISPR & Cas Genes Forecast
10.2 Americas CRISPR & Cas Genes Forecast by Country (2026-2031)
10.2.1 United States Market CRISPR & Cas Genes Forecast
10.2.2 Canada Market CRISPR & Cas Genes Forecast
10.2.3 Mexico Market CRISPR & Cas Genes Forecast
10.2.4 Brazil Market CRISPR & Cas Genes Forecast
10.3 APAC CRISPR & Cas Genes Forecast by Region (2026-2031)
10.3.1 China CRISPR & Cas Genes Market Forecast
10.3.2 Japan Market CRISPR & Cas Genes Forecast
10.3.3 Korea Market CRISPR & Cas Genes Forecast
10.3.4 Southeast Asia Market CRISPR & Cas Genes Forecast
10.3.5 India Market CRISPR & Cas Genes Forecast
10.3.6 Australia Market CRISPR & Cas Genes Forecast
10.4 Europe CRISPR & Cas Genes Forecast by Country (2026-2031)
10.4.1 Germany Market CRISPR & Cas Genes Forecast
10.4.2 France Market CRISPR & Cas Genes Forecast
10.4.3 UK Market CRISPR & Cas Genes Forecast
10.4.4 Italy Market CRISPR & Cas Genes Forecast
10.4.5 Russia Market CRISPR & Cas Genes Forecast
10.5 Middle East & Africa CRISPR & Cas Genes Forecast by Region (2026-2031)
10.5.1 Egypt Market CRISPR & Cas Genes Forecast
10.5.2 South Africa Market CRISPR & Cas Genes Forecast
10.5.3 Israel Market CRISPR & Cas Genes Forecast
10.5.4 Turkey Market CRISPR & Cas Genes Forecast
10.6 Global CRISPR & Cas Genes Forecast by Type (2026-2031)
10.7 Global CRISPR & Cas Genes Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CRISPR & Cas Genes Forecast
11 KEY PLAYERS ANALYSIS
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Information
11.1.2 CRISPR Therapeutics CRISPR & Cas Genes Product Offered
11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 CRISPR Therapeutics Main Business Overview
11.1.5 CRISPR Therapeutics Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca CRISPR & Cas Genes Product Offered
11.2.3 AstraZeneca CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Addgene
11.3.1 Addgene Company Information
11.3.2 Addgene CRISPR & Cas Genes Product Offered
11.3.3 Addgene CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Addgene Main Business Overview
11.3.5 Addgene Latest Developments
11.4 Caribou Biosciences, Inc.
11.4.1 Caribou Biosciences, Inc. Company Information
11.4.2 Caribou Biosciences, Inc. CRISPR & Cas Genes Product Offered
11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Caribou Biosciences, Inc. Main Business Overview
11.4.5 Caribou Biosciences, Inc. Latest Developments
11.5 Cellectis
11.5.1 Cellectis Company Information
11.5.2 Cellectis CRISPR & Cas Genes Product Offered
11.5.3 Cellectis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Cellectis Main Business Overview
11.5.5 Cellectis Latest Developments
11.6 Editas Medicine, Inc.
11.6.1 Editas Medicine, Inc. Company Information
11.6.2 Editas Medicine, Inc. CRISPR & Cas Genes Product Offered
11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Editas Medicine, Inc. Main Business Overview
11.6.5 Editas Medicine, Inc. Latest Developments
11.7 Egenesis
11.7.1 Egenesis Company Information
11.7.2 Egenesis CRISPR & Cas Genes Product Offered
11.7.3 Egenesis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Egenesis Main Business Overview
11.7.5 Egenesis Latest Developments
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Information
11.8.2 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product Offered
11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.8.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.9 Horizon Discovery Group Plc
11.9.1 Horizon Discovery Group Plc Company Information
11.9.2 Horizon Discovery Group Plc CRISPR & Cas Genes Product Offered
11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Horizon Discovery Group Plc Main Business Overview
11.9.5 Horizon Discovery Group Plc Latest Developments
11.10 Genscrip
11.10.1 Genscrip Company Information
11.10.2 Genscrip CRISPR & Cas Genes Product Offered
11.10.3 Genscrip CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Genscrip Main Business Overview
11.10.5 Genscrip Latest Developments
11.11 Danaher Corporation
11.11.1 Danaher Corporation Company Information
11.11.2 Danaher Corporation CRISPR & Cas Genes Product Offered
11.11.3 Danaher Corporation CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Danaher Corporation Main Business Overview
11.11.5 Danaher Corporation Latest Developments
11.12 Intellia Therapeutics, Inc.
11.12.1 Intellia Therapeutics, Inc. Company Information
11.12.2 Intellia Therapeutics, Inc. CRISPR & Cas Genes Product Offered
11.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Intellia Therapeutics, Inc. Main Business Overview
11.12.5 Intellia Therapeutics, Inc. Latest Developments
11.13 Lonza
11.13.1 Lonza Company Information
11.13.2 Lonza CRISPR & Cas Genes Product Offered
11.13.3 Lonza CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Lonza Main Business Overview
11.13.5 Lonza Latest Developments
11.14 Merck KGaA
11.14.1 Merck KGaA Company Information
11.14.2 Merck KGaA CRISPR & Cas Genes Product Offered
11.14.3 Merck KGaA CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Merck KGaA Main Business Overview
11.14.5 Merck KGaA Latest Developments
11.15 New England BioLabs
11.15.1 New England BioLabs Company Information
11.15.2 New England BioLabs CRISPR & Cas Genes Product Offered
11.15.3 New England BioLabs CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 New England BioLabs Main Business Overview
11.15.5 New England BioLabs Latest Developments
11.16 Takara Bio, Inc.
11.16.1 Takara Bio, Inc. Company Information
11.16.2 Takara Bio, Inc. CRISPR & Cas Genes Product Offered
11.16.3 Takara Bio, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Takara Bio, Inc. Main Business Overview
11.16.5 Takara Bio, Inc. Latest Developments
11.17 Synthego
11.17.1 Synthego Company Information
11.17.2 Synthego CRISPR & Cas Genes Product Offered
11.17.3 Synthego CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Synthego Main Business Overview
11.17.5 Synthego Latest Developments
11.18 Mammoth Biosciences
11.18.1 Mammoth Biosciences Company Information
11.18.2 Mammoth Biosciences CRISPR & Cas Genes Product Offered
11.18.3 Mammoth Biosciences CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Mammoth Biosciences Main Business Overview
11.18.5 Mammoth Biosciences Latest Developments
11.19 Inscripta, Inc.
11.19.1 Inscripta, Inc. Company Information
11.19.2 Inscripta, Inc. CRISPR & Cas Genes Product Offered
11.19.3 Inscripta, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Inscripta, Inc. Main Business Overview
11.19.5 Inscripta, Inc. Latest Developments
11.20 Cibus
11.20.1 Cibus Company Information
11.20.2 Cibus CRISPR & Cas Genes Product Offered
11.20.3 Cibus CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Cibus Main Business Overview
11.20.5 Cibus Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CRISPR & Cas Genes Market Size (2020-2031)
2.1.2 CRISPR & Cas Genes Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CRISPR & Cas Genes by Country/Region (2020, 2024 & 2031)
2.2 CRISPR & Cas Genes Segment by Type
2.2.1 Vector-based Cas
2.2.2 DNA-free Cas
2.2.3 Cell Line Engineering
2.3 CRISPR & Cas Genes Market Size by Type
2.3.1 CRISPR & Cas Genes Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
2.4 CRISPR & Cas Genes Segment by Application
2.4.1 Biotechnology and Pharmaceutical Companies
2.4.2 Academics and Government Research Institutes
2.4.3 Contract Research Organizations (CROs)
2.5 CRISPR & Cas Genes Market Size by Application
2.5.1 CRISPR & Cas Genes Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
3 CRISPR & CAS GENES MARKET SIZE BY PLAYER
3.1 CRISPR & Cas Genes Market Size Market Share by Player
3.1.1 Global CRISPR & Cas Genes Revenue by Player (2020-2025)
3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Player (2020-2025)
3.2 Global CRISPR & Cas Genes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR & CAS GENES BY REGION
4.1 CRISPR & Cas Genes Market Size by Region (2020-2025)
4.2 Global CRISPR & Cas Genes Annual Revenue by Country/Region (2020-2025)
4.3 Americas CRISPR & Cas Genes Market Size Growth (2020-2025)
4.4 APAC CRISPR & Cas Genes Market Size Growth (2020-2025)
4.5 Europe CRISPR & Cas Genes Market Size Growth (2020-2025)
4.6 Middle East & Africa CRISPR & Cas Genes Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CRISPR & Cas Genes Market Size by Country (2020-2025)
5.2 Americas CRISPR & Cas Genes Market Size by Type (2020-2025)
5.3 Americas CRISPR & Cas Genes Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR & Cas Genes Market Size by Region (2020-2025)
6.2 APAC CRISPR & Cas Genes Market Size by Type (2020-2025)
6.3 APAC CRISPR & Cas Genes Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CRISPR & Cas Genes Market Size by Country (2020-2025)
7.2 Europe CRISPR & Cas Genes Market Size by Type (2020-2025)
7.3 Europe CRISPR & Cas Genes Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CRISPR & Cas Genes by Region (2020-2025)
8.2 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2020-2025)
8.3 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CRISPR & CAS GENES MARKET FORECAST
10.1 Global CRISPR & Cas Genes Forecast by Region (2026-2031)
10.1.1 Global CRISPR & Cas Genes Forecast by Region (2026-2031)
10.1.2 Americas CRISPR & Cas Genes Forecast
10.1.3 APAC CRISPR & Cas Genes Forecast
10.1.4 Europe CRISPR & Cas Genes Forecast
10.1.5 Middle East & Africa CRISPR & Cas Genes Forecast
10.2 Americas CRISPR & Cas Genes Forecast by Country (2026-2031)
10.2.1 United States Market CRISPR & Cas Genes Forecast
10.2.2 Canada Market CRISPR & Cas Genes Forecast
10.2.3 Mexico Market CRISPR & Cas Genes Forecast
10.2.4 Brazil Market CRISPR & Cas Genes Forecast
10.3 APAC CRISPR & Cas Genes Forecast by Region (2026-2031)
10.3.1 China CRISPR & Cas Genes Market Forecast
10.3.2 Japan Market CRISPR & Cas Genes Forecast
10.3.3 Korea Market CRISPR & Cas Genes Forecast
10.3.4 Southeast Asia Market CRISPR & Cas Genes Forecast
10.3.5 India Market CRISPR & Cas Genes Forecast
10.3.6 Australia Market CRISPR & Cas Genes Forecast
10.4 Europe CRISPR & Cas Genes Forecast by Country (2026-2031)
10.4.1 Germany Market CRISPR & Cas Genes Forecast
10.4.2 France Market CRISPR & Cas Genes Forecast
10.4.3 UK Market CRISPR & Cas Genes Forecast
10.4.4 Italy Market CRISPR & Cas Genes Forecast
10.4.5 Russia Market CRISPR & Cas Genes Forecast
10.5 Middle East & Africa CRISPR & Cas Genes Forecast by Region (2026-2031)
10.5.1 Egypt Market CRISPR & Cas Genes Forecast
10.5.2 South Africa Market CRISPR & Cas Genes Forecast
10.5.3 Israel Market CRISPR & Cas Genes Forecast
10.5.4 Turkey Market CRISPR & Cas Genes Forecast
10.6 Global CRISPR & Cas Genes Forecast by Type (2026-2031)
10.7 Global CRISPR & Cas Genes Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CRISPR & Cas Genes Forecast
11 KEY PLAYERS ANALYSIS
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Information
11.1.2 CRISPR Therapeutics CRISPR & Cas Genes Product Offered
11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 CRISPR Therapeutics Main Business Overview
11.1.5 CRISPR Therapeutics Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca CRISPR & Cas Genes Product Offered
11.2.3 AstraZeneca CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Addgene
11.3.1 Addgene Company Information
11.3.2 Addgene CRISPR & Cas Genes Product Offered
11.3.3 Addgene CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Addgene Main Business Overview
11.3.5 Addgene Latest Developments
11.4 Caribou Biosciences, Inc.
11.4.1 Caribou Biosciences, Inc. Company Information
11.4.2 Caribou Biosciences, Inc. CRISPR & Cas Genes Product Offered
11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Caribou Biosciences, Inc. Main Business Overview
11.4.5 Caribou Biosciences, Inc. Latest Developments
11.5 Cellectis
11.5.1 Cellectis Company Information
11.5.2 Cellectis CRISPR & Cas Genes Product Offered
11.5.3 Cellectis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Cellectis Main Business Overview
11.5.5 Cellectis Latest Developments
11.6 Editas Medicine, Inc.
11.6.1 Editas Medicine, Inc. Company Information
11.6.2 Editas Medicine, Inc. CRISPR & Cas Genes Product Offered
11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Editas Medicine, Inc. Main Business Overview
11.6.5 Editas Medicine, Inc. Latest Developments
11.7 Egenesis
11.7.1 Egenesis Company Information
11.7.2 Egenesis CRISPR & Cas Genes Product Offered
11.7.3 Egenesis CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Egenesis Main Business Overview
11.7.5 Egenesis Latest Developments
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Information
11.8.2 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product Offered
11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.8.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.9 Horizon Discovery Group Plc
11.9.1 Horizon Discovery Group Plc Company Information
11.9.2 Horizon Discovery Group Plc CRISPR & Cas Genes Product Offered
11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Horizon Discovery Group Plc Main Business Overview
11.9.5 Horizon Discovery Group Plc Latest Developments
11.10 Genscrip
11.10.1 Genscrip Company Information
11.10.2 Genscrip CRISPR & Cas Genes Product Offered
11.10.3 Genscrip CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Genscrip Main Business Overview
11.10.5 Genscrip Latest Developments
11.11 Danaher Corporation
11.11.1 Danaher Corporation Company Information
11.11.2 Danaher Corporation CRISPR & Cas Genes Product Offered
11.11.3 Danaher Corporation CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Danaher Corporation Main Business Overview
11.11.5 Danaher Corporation Latest Developments
11.12 Intellia Therapeutics, Inc.
11.12.1 Intellia Therapeutics, Inc. Company Information
11.12.2 Intellia Therapeutics, Inc. CRISPR & Cas Genes Product Offered
11.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Intellia Therapeutics, Inc. Main Business Overview
11.12.5 Intellia Therapeutics, Inc. Latest Developments
11.13 Lonza
11.13.1 Lonza Company Information
11.13.2 Lonza CRISPR & Cas Genes Product Offered
11.13.3 Lonza CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Lonza Main Business Overview
11.13.5 Lonza Latest Developments
11.14 Merck KGaA
11.14.1 Merck KGaA Company Information
11.14.2 Merck KGaA CRISPR & Cas Genes Product Offered
11.14.3 Merck KGaA CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Merck KGaA Main Business Overview
11.14.5 Merck KGaA Latest Developments
11.15 New England BioLabs
11.15.1 New England BioLabs Company Information
11.15.2 New England BioLabs CRISPR & Cas Genes Product Offered
11.15.3 New England BioLabs CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 New England BioLabs Main Business Overview
11.15.5 New England BioLabs Latest Developments
11.16 Takara Bio, Inc.
11.16.1 Takara Bio, Inc. Company Information
11.16.2 Takara Bio, Inc. CRISPR & Cas Genes Product Offered
11.16.3 Takara Bio, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Takara Bio, Inc. Main Business Overview
11.16.5 Takara Bio, Inc. Latest Developments
11.17 Synthego
11.17.1 Synthego Company Information
11.17.2 Synthego CRISPR & Cas Genes Product Offered
11.17.3 Synthego CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Synthego Main Business Overview
11.17.5 Synthego Latest Developments
11.18 Mammoth Biosciences
11.18.1 Mammoth Biosciences Company Information
11.18.2 Mammoth Biosciences CRISPR & Cas Genes Product Offered
11.18.3 Mammoth Biosciences CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Mammoth Biosciences Main Business Overview
11.18.5 Mammoth Biosciences Latest Developments
11.19 Inscripta, Inc.
11.19.1 Inscripta, Inc. Company Information
11.19.2 Inscripta, Inc. CRISPR & Cas Genes Product Offered
11.19.3 Inscripta, Inc. CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Inscripta, Inc. Main Business Overview
11.19.5 Inscripta, Inc. Latest Developments
11.20 Cibus
11.20.1 Cibus Company Information
11.20.2 Cibus CRISPR & Cas Genes Product Offered
11.20.3 Cibus CRISPR & Cas Genes Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Cibus Main Business Overview
11.20.5 Cibus Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CRISPR & Cas Genes Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CRISPR & Cas Genes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vector-based Cas
Table 4. Major Players of DNA-free Cas
Table 5. Major Players of Cell Line Engineering
Table 6. CRISPR & Cas Genes Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 8. Global CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Table 9. CRISPR & Cas Genes Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 11. Global CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Table 12. Global CRISPR & Cas Genes Revenue by Player (2020-2025) & ($ millions)
Table 13. Global CRISPR & Cas Genes Revenue Market Share by Player (2020-2025)
Table 14. CRISPR & Cas Genes Key Players Head office and Products Offered
Table 15. CRISPR & Cas Genes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CRISPR & Cas Genes Market Size by Region (2020-2025) & ($ millions)
Table 19. Global CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Table 20. Global CRISPR & Cas Genes Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global CRISPR & Cas Genes Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas CRISPR & Cas Genes Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas CRISPR & Cas Genes Market Size Market Share by Country (2020-2025)
Table 24. Americas CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Table 26. Americas CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Table 28. APAC CRISPR & Cas Genes Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Table 30. APAC CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe CRISPR & Cas Genes Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe CRISPR & Cas Genes Market Size Market Share by Country (2020-2025)
Table 34. Europe CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa CRISPR & Cas Genes Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CRISPR & Cas Genes
Table 40. Key Market Challenges & Risks of CRISPR & Cas Genes
Table 41. Key Industry Trends of CRISPR & Cas Genes
Table 42. Global CRISPR & Cas Genes Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global CRISPR & Cas Genes Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global CRISPR & Cas Genes Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global CRISPR & Cas Genes Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. CRISPR Therapeutics Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 47. CRISPR Therapeutics CRISPR & Cas Genes Product Offered
Table 48. CRISPR Therapeutics CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. CRISPR Therapeutics Main Business
Table 50. CRISPR Therapeutics Latest Developments
Table 51. AstraZeneca Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 52. AstraZeneca CRISPR & Cas Genes Product Offered
Table 53. AstraZeneca CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Addgene Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 57. Addgene CRISPR & Cas Genes Product Offered
Table 58. Addgene CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Addgene Main Business
Table 60. Addgene Latest Developments
Table 61. Caribou Biosciences, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 62. Caribou Biosciences, Inc. CRISPR & Cas Genes Product Offered
Table 63. Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Caribou Biosciences, Inc. Main Business
Table 65. Caribou Biosciences, Inc. Latest Developments
Table 66. Cellectis Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 67. Cellectis CRISPR & Cas Genes Product Offered
Table 68. Cellectis CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Cellectis Main Business
Table 70. Cellectis Latest Developments
Table 71. Editas Medicine, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 72. Editas Medicine, Inc. CRISPR & Cas Genes Product Offered
Table 73. Editas Medicine, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Editas Medicine, Inc. Main Business
Table 75. Editas Medicine, Inc. Latest Developments
Table 76. Egenesis Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 77. Egenesis CRISPR & Cas Genes Product Offered
Table 78. Egenesis CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Egenesis Main Business
Table 80. Egenesis Latest Developments
Table 81. F. Hoffmann-La Roche Ltd. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 82. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product Offered
Table 83. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. F. Hoffmann-La Roche Ltd. Main Business
Table 85. F. Hoffmann-La Roche Ltd. Latest Developments
Table 86. Horizon Discovery Group Plc Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 87. Horizon Discovery Group Plc CRISPR & Cas Genes Product Offered
Table 88. Horizon Discovery Group Plc CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Horizon Discovery Group Plc Main Business
Table 90. Horizon Discovery Group Plc Latest Developments
Table 91. Genscrip Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 92. Genscrip CRISPR & Cas Genes Product Offered
Table 93. Genscrip CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Genscrip Main Business
Table 95. Genscrip Latest Developments
Table 96. Danaher Corporation Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 97. Danaher Corporation CRISPR & Cas Genes Product Offered
Table 98. Danaher Corporation CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Danaher Corporation Main Business
Table 100. Danaher Corporation Latest Developments
Table 101. Intellia Therapeutics, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 102. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product Offered
Table 103. Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Intellia Therapeutics, Inc. Main Business
Table 105. Intellia Therapeutics, Inc. Latest Developments
Table 106. Lonza Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 107. Lonza CRISPR & Cas Genes Product Offered
Table 108. Lonza CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Lonza Main Business
Table 110. Lonza Latest Developments
Table 111. Merck KGaA Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 112. Merck KGaA CRISPR & Cas Genes Product Offered
Table 113. Merck KGaA CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Merck KGaA Main Business
Table 115. Merck KGaA Latest Developments
Table 116. New England BioLabs Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 117. New England BioLabs CRISPR & Cas Genes Product Offered
Table 118. New England BioLabs CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. New England BioLabs Main Business
Table 120. New England BioLabs Latest Developments
Table 121. Takara Bio, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 122. Takara Bio, Inc. CRISPR & Cas Genes Product Offered
Table 123. Takara Bio, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Takara Bio, Inc. Main Business
Table 125. Takara Bio, Inc. Latest Developments
Table 126. Synthego Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 127. Synthego CRISPR & Cas Genes Product Offered
Table 128. Synthego CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Synthego Main Business
Table 130. Synthego Latest Developments
Table 131. Mammoth Biosciences Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 132. Mammoth Biosciences CRISPR & Cas Genes Product Offered
Table 133. Mammoth Biosciences CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Mammoth Biosciences Main Business
Table 135. Mammoth Biosciences Latest Developments
Table 136. Inscripta, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 137. Inscripta, Inc. CRISPR & Cas Genes Product Offered
Table 138. Inscripta, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Inscripta, Inc. Main Business
Table 140. Inscripta, Inc. Latest Developments
Table 141. Cibus Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 142. Cibus CRISPR & Cas Genes Product Offered
Table 143. Cibus CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Cibus Main Business
Table 145. Cibus Latest Developments
Table 1. CRISPR & Cas Genes Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CRISPR & Cas Genes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vector-based Cas
Table 4. Major Players of DNA-free Cas
Table 5. Major Players of Cell Line Engineering
Table 6. CRISPR & Cas Genes Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 8. Global CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Table 9. CRISPR & Cas Genes Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 11. Global CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Table 12. Global CRISPR & Cas Genes Revenue by Player (2020-2025) & ($ millions)
Table 13. Global CRISPR & Cas Genes Revenue Market Share by Player (2020-2025)
Table 14. CRISPR & Cas Genes Key Players Head office and Products Offered
Table 15. CRISPR & Cas Genes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CRISPR & Cas Genes Market Size by Region (2020-2025) & ($ millions)
Table 19. Global CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Table 20. Global CRISPR & Cas Genes Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global CRISPR & Cas Genes Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas CRISPR & Cas Genes Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas CRISPR & Cas Genes Market Size Market Share by Country (2020-2025)
Table 24. Americas CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Table 26. Americas CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Table 28. APAC CRISPR & Cas Genes Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Table 30. APAC CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe CRISPR & Cas Genes Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe CRISPR & Cas Genes Market Size Market Share by Country (2020-2025)
Table 34. Europe CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa CRISPR & Cas Genes Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa CRISPR & Cas Genes Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa CRISPR & Cas Genes Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CRISPR & Cas Genes
Table 40. Key Market Challenges & Risks of CRISPR & Cas Genes
Table 41. Key Industry Trends of CRISPR & Cas Genes
Table 42. Global CRISPR & Cas Genes Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global CRISPR & Cas Genes Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global CRISPR & Cas Genes Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global CRISPR & Cas Genes Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. CRISPR Therapeutics Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 47. CRISPR Therapeutics CRISPR & Cas Genes Product Offered
Table 48. CRISPR Therapeutics CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. CRISPR Therapeutics Main Business
Table 50. CRISPR Therapeutics Latest Developments
Table 51. AstraZeneca Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 52. AstraZeneca CRISPR & Cas Genes Product Offered
Table 53. AstraZeneca CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Addgene Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 57. Addgene CRISPR & Cas Genes Product Offered
Table 58. Addgene CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Addgene Main Business
Table 60. Addgene Latest Developments
Table 61. Caribou Biosciences, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 62. Caribou Biosciences, Inc. CRISPR & Cas Genes Product Offered
Table 63. Caribou Biosciences, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Caribou Biosciences, Inc. Main Business
Table 65. Caribou Biosciences, Inc. Latest Developments
Table 66. Cellectis Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 67. Cellectis CRISPR & Cas Genes Product Offered
Table 68. Cellectis CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Cellectis Main Business
Table 70. Cellectis Latest Developments
Table 71. Editas Medicine, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 72. Editas Medicine, Inc. CRISPR & Cas Genes Product Offered
Table 73. Editas Medicine, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Editas Medicine, Inc. Main Business
Table 75. Editas Medicine, Inc. Latest Developments
Table 76. Egenesis Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 77. Egenesis CRISPR & Cas Genes Product Offered
Table 78. Egenesis CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Egenesis Main Business
Table 80. Egenesis Latest Developments
Table 81. F. Hoffmann-La Roche Ltd. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 82. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Product Offered
Table 83. F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. F. Hoffmann-La Roche Ltd. Main Business
Table 85. F. Hoffmann-La Roche Ltd. Latest Developments
Table 86. Horizon Discovery Group Plc Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 87. Horizon Discovery Group Plc CRISPR & Cas Genes Product Offered
Table 88. Horizon Discovery Group Plc CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Horizon Discovery Group Plc Main Business
Table 90. Horizon Discovery Group Plc Latest Developments
Table 91. Genscrip Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 92. Genscrip CRISPR & Cas Genes Product Offered
Table 93. Genscrip CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Genscrip Main Business
Table 95. Genscrip Latest Developments
Table 96. Danaher Corporation Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 97. Danaher Corporation CRISPR & Cas Genes Product Offered
Table 98. Danaher Corporation CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Danaher Corporation Main Business
Table 100. Danaher Corporation Latest Developments
Table 101. Intellia Therapeutics, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 102. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product Offered
Table 103. Intellia Therapeutics, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Intellia Therapeutics, Inc. Main Business
Table 105. Intellia Therapeutics, Inc. Latest Developments
Table 106. Lonza Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 107. Lonza CRISPR & Cas Genes Product Offered
Table 108. Lonza CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Lonza Main Business
Table 110. Lonza Latest Developments
Table 111. Merck KGaA Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 112. Merck KGaA CRISPR & Cas Genes Product Offered
Table 113. Merck KGaA CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Merck KGaA Main Business
Table 115. Merck KGaA Latest Developments
Table 116. New England BioLabs Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 117. New England BioLabs CRISPR & Cas Genes Product Offered
Table 118. New England BioLabs CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. New England BioLabs Main Business
Table 120. New England BioLabs Latest Developments
Table 121. Takara Bio, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 122. Takara Bio, Inc. CRISPR & Cas Genes Product Offered
Table 123. Takara Bio, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Takara Bio, Inc. Main Business
Table 125. Takara Bio, Inc. Latest Developments
Table 126. Synthego Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 127. Synthego CRISPR & Cas Genes Product Offered
Table 128. Synthego CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Synthego Main Business
Table 130. Synthego Latest Developments
Table 131. Mammoth Biosciences Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 132. Mammoth Biosciences CRISPR & Cas Genes Product Offered
Table 133. Mammoth Biosciences CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Mammoth Biosciences Main Business
Table 135. Mammoth Biosciences Latest Developments
Table 136. Inscripta, Inc. Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 137. Inscripta, Inc. CRISPR & Cas Genes Product Offered
Table 138. Inscripta, Inc. CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Inscripta, Inc. Main Business
Table 140. Inscripta, Inc. Latest Developments
Table 141. Cibus Details, Company Type, CRISPR & Cas Genes Area Served and Its Competitors
Table 142. Cibus CRISPR & Cas Genes Product Offered
Table 143. Cibus CRISPR & Cas Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Cibus Main Business
Table 145. Cibus Latest Developments
LIST OF FIGURES
Figure 1. CRISPR & Cas Genes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR & Cas Genes Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CRISPR & Cas Genes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CRISPR & Cas Genes Sales Market Share by Country/Region (2024)
Figure 8. CRISPR & Cas Genes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CRISPR & Cas Genes Market Size Market Share by Type in 2024
Figure 10. CRISPR & Cas Genes in Biotechnology and Pharmaceutical Companies
Figure 11. Global CRISPR & Cas Genes Market: Biotechnology and Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 12. CRISPR & Cas Genes in Academics and Government Research Institutes
Figure 13. Global CRISPR & Cas Genes Market: Academics and Government Research Institutes (2020-2025) & ($ millions)
Figure 14. CRISPR & Cas Genes in Contract Research Organizations (CROs)
Figure 15. Global CRISPR & Cas Genes Market: Contract Research Organizations (CROs) (2020-2025) & ($ millions)
Figure 16. Global CRISPR & Cas Genes Market Size Market Share by Application in 2024
Figure 17. Global CRISPR & Cas Genes Revenue Market Share by Player in 2024
Figure 18. Global CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Figure 19. Americas CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 20. APAC CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 21. Europe CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 23. Americas CRISPR & Cas Genes Value Market Share by Country in 2024
Figure 24. United States CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC CRISPR & Cas Genes Market Size Market Share by Region in 2024
Figure 29. APAC CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Figure 30. APAC CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Figure 31. China CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 35. India CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe CRISPR & Cas Genes Market Size Market Share by Country in 2024
Figure 38. Europe CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Figure 39. Europe CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Figure 40. Germany CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 41. France CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 42. UK CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Figure 48. Egypt CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 54. APAC CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 55. Europe CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 57. United States CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 58. Canada CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 59. Mexico CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 60. Brazil CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 61. China CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 62. Japan CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 63. Korea CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 65. India CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 66. Australia CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 67. Germany CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 68. France CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 69. UK CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 70. Italy CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 71. Russia CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 72. Egypt CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 73. South Africa CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 74. Israel CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 75. Turkey CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 76. Global CRISPR & Cas Genes Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global CRISPR & Cas Genes Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 1. CRISPR & Cas Genes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR & Cas Genes Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CRISPR & Cas Genes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CRISPR & Cas Genes Sales Market Share by Country/Region (2024)
Figure 8. CRISPR & Cas Genes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CRISPR & Cas Genes Market Size Market Share by Type in 2024
Figure 10. CRISPR & Cas Genes in Biotechnology and Pharmaceutical Companies
Figure 11. Global CRISPR & Cas Genes Market: Biotechnology and Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 12. CRISPR & Cas Genes in Academics and Government Research Institutes
Figure 13. Global CRISPR & Cas Genes Market: Academics and Government Research Institutes (2020-2025) & ($ millions)
Figure 14. CRISPR & Cas Genes in Contract Research Organizations (CROs)
Figure 15. Global CRISPR & Cas Genes Market: Contract Research Organizations (CROs) (2020-2025) & ($ millions)
Figure 16. Global CRISPR & Cas Genes Market Size Market Share by Application in 2024
Figure 17. Global CRISPR & Cas Genes Revenue Market Share by Player in 2024
Figure 18. Global CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Figure 19. Americas CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 20. APAC CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 21. Europe CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa CRISPR & Cas Genes Market Size 2020-2025 ($ millions)
Figure 23. Americas CRISPR & Cas Genes Value Market Share by Country in 2024
Figure 24. United States CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC CRISPR & Cas Genes Market Size Market Share by Region in 2024
Figure 29. APAC CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Figure 30. APAC CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Figure 31. China CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 35. India CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe CRISPR & Cas Genes Market Size Market Share by Country in 2024
Figure 38. Europe CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Figure 39. Europe CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Figure 40. Germany CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 41. France CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 42. UK CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa CRISPR & Cas Genes Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa CRISPR & Cas Genes Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa CRISPR & Cas Genes Market Size Market Share by Application (2020-2025)
Figure 48. Egypt CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries CRISPR & Cas Genes Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 54. APAC CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 55. Europe CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 57. United States CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 58. Canada CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 59. Mexico CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 60. Brazil CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 61. China CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 62. Japan CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 63. Korea CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 65. India CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 66. Australia CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 67. Germany CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 68. France CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 69. UK CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 70. Italy CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 71. Russia CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 72. Egypt CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 73. South Africa CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 74. Israel CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 75. Turkey CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
Figure 76. Global CRISPR & Cas Genes Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global CRISPR & Cas Genes Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries CRISPR & Cas Genes Market Size 2026-2031 ($ millions)
More Publications
Global Bone Densitometer Market Growth 2025-2031
US$ 3,660.00
January 2025
137 pages
Global Coronary Flow Meter Market Growth 2024-2030
US$ 3,660.00
December 2024
98 pages
Global Flexible Endoscopes Market Growth 2025-2031
US$ 3,660.00
January 2025
103 pages
Global Intraoperative MRI Market Growth 2025-2031
US$ 3,660.00
December 2024
76 pages
Global PD-L1 Biomarker Testing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
August 2025
81 pages
